Medifron DBT Co. Ltd Capital Reinvestment Ratio
Medifron DBT Co. Ltd capital reinvestment ratio. Medifron DBT Co. Ltd (065650) has a Capital Reinvestment Ratio of 0.00x as of June 2025, meaning it reinvests 0% of its operating cash flow (₩6.72 Billion) in capital expenditures (₩22.85 Million). Check 065650 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Medifron DBT Co. Ltd (2011–2014)
Capital reinvestment ratio of Medifron DBT Co. Ltd from 2011 to 2014. This chart tracks Medifron DBT Co. Ltd's Capital Reinvestment Ratio across 2 annual periods. Also explore net asset momentum of Medifron DBT Co. Ltd to track the company's year-over-year net asset growth rate.
Medifron DBT Co. Ltd Capital Reinvestment Ratio by Year (2011–2014)
Medifron DBT Co. Ltd capital reinvestment ratio by year from 2011 to 2014. For the full cash flow conversion analysis, see 065650 operating cash flow.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2014 | 38.34x | ₩701.96K | ₩26.91 Million | ▲ +129467.7% |
| 2011 | 0.03x | ₩912.56 Million | ₩27.00 Million | — |